Gene And Cell Therapies In Asia: New Korean Law To Change Landscape Of Cutting Edge Biologics
Invossa Affair Still Hangs Heavy
South Korea will undergo many changes as it gears up for a new law on cutting edge regenerative medicine and biologics, which will be implemented next year. Until then, further discussions will be needed to set details of the rules that can step up the industry’s competitiveness and bring the country more in line with global standards.
